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Abstract 
HtrA is a complex, multimeric chaperone and serine protease important for the 
virulence and survival of many bacteria.  Chlamydia trachomatis is an obligate, 
intracellular bacterial pathogen that is responsible for severe disease pathology.  C. 
trachomatis HtrA (CtHtrA) has been shown to be highly expressed in laboratory models 
of disease.  In this study, molecular modelling of CtHtrA protein active site structure 
identified putative S1 – 3 subsite residues I242, I265, and V266.  These residues were 
altered by site-directed mutagenesis and these changes were shown to considerably 
reduce protease activity on known substrates and resulted in a narrower and distinct 
range of substrates compared to wildtype.  Bacterial two hybrid analysis revealed that 
CtHtrA is able to interact in vivo with a broad range of protein sequences with high 
affinity.  Notably, however, the interaction was significantly altered in 35 out of 69 
clones when residue V266 was mutated indicating that this residue has an important 
function during substrate binding.   
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Introduction 
Chlamydia (C.) trachomatis is an obligate intracellular pathogen responsible for the 
highest number of sexually-transmitted bacterial infections throughout the world [WHO, 
2011].  Infections are frequently asymptomatic and without treatment can result in long-term 
health problems [Ghinsberg and Nitzan, 1994].  One explanation for the severe disease 
pathology is that the inflammatory response to ascending persistent chlamydial infections 
results in irreparable tissue damage [Witkin and Linhares, 2002].  Analysis of laboratory 
models of chlamydial persistence identified high levels of HtrA (high temperature 
requirement A) [Belland, Nelson et al., 2003].  C. trachomatis HtrA (CtHtrA) is an 
extracytoplasmic (likely periplasmic), serine protease with chaperone and proteolytic activity 
and demonstrates broad sequence specificity [Huston, Swedberg et al., 2007].  Chlamydia is 
not able to be genetically manipulated and hence in vitro strategies to understand the 
biochemical function of proteins from this important pathogen provide an alternative 
investigative means.  A variety of bacteria require HtrA for their survival under certain stress 
conditions. HtrA is also an important virulence factor for a number of pathogens, including; 
Helicobacter pylori, Bordetella pertussis and Bacillus anthracis [Hoy, Lower et al., 2010; 
Baud, Gutsche et al., 2011; Chitlaru, Zaide et al., 2011].   Biochemically it is known that 
HtrA degrades misfolded proteins during stress conditions and additionally is a chaperone for 
outer membrane protein  assembly [Poquet, Saint et al., 2000; Hoy, Lower et al., 2010; Baud, 
Gutsche et al., 2011; Chitlaru, Zaide et al., 2011].  Substrate binding of HtrA occurs initially 
in the PDZ domain, which leads to conformational changes and subsequent oligomerisation 
to allow formation of active oligomeric complexes [Krojer, Sawa et al., 2010].  During 
oligomerisation, the L1 and L2 loops break their interactions with the protruding LA loop 
from the neighbouring monomer, and arrange into an ordered conformation with resolved 
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subsite pockets to facilitate proteolysis [Krojer, Sawa et al., 2010].  Studies on the role of the 
L2 loop in Escherichia coli HtrA/DegP (EcHtrA) have shown that the L2 loop, in particular 
the apical region, is necessary for correct active site conformation [Sobiecka-Szkatula, 
Gieldon et al., 2010].  Key residues in EcHtrA were identified which are involved in the 
stabilisation of the L2 loop, in particular residue L229 which when mutated, completely 
eliminated the proteolytic activity [Sobiecka-Szkatula, Gieldon et al., 2010].  In the present 
study we conducted a molecular investigation of CtHtrA active site binding specificity, 
focusing particularly on the role of residues in the L2 loop.  
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Results and Discussion 
 
V266 is predicted to be involved in forming the S1binding pocket of CtHtrA 
The structure of CtHtrA was modelled to predict the residues involved in forming the 
active site binding cleft. Models were generated for both the inactive hexameric form based 
on EcHtrA as well as an active form based on E. coli DegS [Huston, Tyndall et al., 2011]. 
The model was used to identify putative active site binding residues I242, I265, and V266 
which are likely to be involved in forming the S1-3 pockets of the structure (Fig. 1 A and B). 
The structural loops around the active site of CtHtrA and EcHtrA are well conserved (Fig. 1 
C).  Therefore there can be some confidence that these residues are important for substrate 
specificity as the structural loops of EcHtrA, in particular the L2 loop, have been shown to be 
involved in substrate binding by forming the S1 specificity pocket [Krojer, Garrido-Franco et 
al., 2002; Krojer, Sawa et al., 2008; Sobiecka-Szkatula, Gieldon et al., 2010].  A microbial 
protein BLAST and alignment of the results for CtHtrA loop 1 and 2 revealed that from 250 
returned matches, I242 and I265 were conserved in 99% of sequences.  The conservation of 
isoleucine among the different bacterial species implies that these residues may play a critical 
role in the structural integrity of the active site rather than in specificity.  In contrast however, 
only 76% of the aligned BLAST sequences contained a non-polar residue with branched side 
chains in the CtHtrA V266 position with only 10% having a conserved valine.  Different 
bacterial HtrA potentially have different substrate specificity therefore a reduced 
conservation of branched non-polar residues, and less still with valine, in the 266 position 
suggests that this particular residue is potentially involved in binding specificity.  To 
investigate this, each of these residues in CtHtrA was altered and the protein analysed in 
proteolytic assays. 
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The identified L2 loop residues are important for protease activity and substrate 
specificity 
In order to assess the role that these CtHtrA L2 loop residues have in substrate 
specificity, they were altered by site-directed mutagenesis and the proteins purified and 
examined for proteolytic activity and specificity. The V266G (S1 subsite), I265G (S2 
subsite), and V266G-I242G mutant versions of CtHtrA considerably reduced the protease 
activity of the specific substrates and showed a narrower range of substrates compared to 
wildtype CtHtrA (wtCtHtrA) (Table 1). CtHtrA activity for these substrates was previously 
published by Huston et al. 2011 [Huston, Tyndall et al., 2011].  The reduced activity 
observed in the mutated proteins is consistent with a previous study on EcHtrA, where all 
mutations in the active site affected β-casein hydrolysis activity except I228N [Sobiecka-
Szkatula, Gieldon et al., 2010].  All mutated proteins were able to hydrolyse -casein when 
assessed by conducting the assay and subsequently monitoring the remaining amount of -
casein using Coomassie stained PAGE. The peptide substrates that were hydrolysed by the 
mutated CtHrA proteins examined here, did not indicate a marked alteration in the substrate 
specificity of CtHtrA at P1 or P2. The mutated proteins cleaved very few of the peptides 
known to be CtHtrA substrates and it is interesting that they retained activity (albeit lower 
binding and catalytic turnover) on the two shorter peptides (MFKLI-pNA and FKLI-pNA).  
DPMFKLV-pNA was an efficient substrate for wtCtHtrA and the double mutant, but was not 
cleaved by the proteins with single mutations in the active site.  Interestingly, all three 
mutated proteins showed a lower Km (increased binding) to the peptide with P at P1, even 
I265G, despite this residue being predicted to be a site two binding pocket residue.  EcHtrA 
has also been shown to preferentially cleave non-polar, hydrophobic substrates, most often at 
valine [Jones, Dexter et al., 2002]. This is also the case for CtHtrA, with the data here 
supporting a key role in L2 loop residues for binding and specificity for protease activity.  
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The double mutant cleaved two substrates which were not cleaved by wtCtHtrA 
(GGGAAPL-pNA and GGGEHTV-pNA) further supporting that the L2 loop residues do 
influence the binding specificity of CtHtrA. These were GGGAAPL-pNA and GGGEHTV-
pNA which represent model chymotrypsin and elastase substrates respectively, with 
additional residues to lengthen the peptide.  To determine, whether the loss of cleavage in the 
mutants, particularly V266G, was due to binding recognition or the structural integrity of the 
active site an in vivo molecular binding assay was employed. 
 
 
CtHtrA has broad sequence specificity in vivo, which appears to favour sequences with 
an α-helix secondary structure 
To further investigate CtHtrA active site binding, an in vivo approach was employed.  
Due to the lack of a suitable genetic manipulation system for Chlamydia a bacterial two 
hybrid approach was employed.  To determine if it is possible to utilise this system for 
CtHtrA, a successful positive CtHtrA control was required.  WtCtHtrA and S247A (CtHtrA 
with the active site serine altered to an alanine to ablate protease activity) were individually 
cloned into the complementary vectors of the BACTH system and then co-transformed into 
DHP-1.  A positive interaction was expected as HtrA forms homo-oligomers, however this 
was not observed when wtCtHtrA was present on both plasmids.  HtrA is known to undergo 
self cleavage therefore the inability to detect wtCtHtrA self-interaction may be due to this 
activity.   When S247A was cloned into both vectors however, a positive interaction was 
observed, providing a positive control and evidence that CtHtrA binding can be assessed 
using this method.  
Previous studies in a variety of bacteria have shown that HtrA is vital for chaperoning and 
hydrolysing outer membrane proteins to allow for correct assembly [Poquet, Saint et al., 
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2000; Baud, Gutsche et al., 2011; Chitlaru, Zaide et al., 2011].  This chaperone activity is 
believed to be mediated by assembly of HtrA homo-oligomers (up to 24-mer) around the 
protein substrate [Krojer, Garrido-Franco et al., 2002]. Whilst homo-oligomers and substrate 
binding cannot be detected in this bacterial two-hybrid, the trigger for this assembly is 
thought to be by the HtrA PDZ1 binding by a single protein C-terminal sequence [Krojer, 
Pangerl et al., 2008]. Two membrane proteins which are candidate substrates for triggering 
HtrA activation by C-terminal binding to the PDZ1 domain were selected from the 
Chlamydia genome to be cloned and tested using the bacterial two-hybrid. In order to control 
for non-specific interactions both C-terminal and internal fragments of two candidate 
membrane associated substrates were cloned (both excluding predicted transmembrane 
domains). As a control a soluble protein was also tested for binding to CtHtrA in the bacterial 
two hybrid. These candidates were YscC, outer membrane component of the type three 
secretion system, GspD, outer membrane component of the type two secretion system, and 
Mip, a secreted protein.  These genes were cloned into both T25 vector orientations of the 
BACTH system and screened with S247A in both T18 orientations, however none of the 
candidates demonstrated a positive interaction with S247A (data not shown). Thus, either 
these are not substrates for CtHtrA, or CtHtrA binding to protein substrates is only transient 
or not possible when it is monomeric based interactions such as in this system.  The initial 
step in triggering the HtrA activation cascade is believed to be direct binding to a single 
PDZ1 hence if these candidates were substrates which could bind to PDZ1 they would have 
been detected in this assay.  
To further test if there is a in vivo sequence specificity for CtHtrA binding a smaller 
fragment size random clone library was generated in the BACTH vector pKNT25 and 
screened against pUT18C-S247A.  The N-terminus of substrates enters HtrA’s active site for 
processing hence cloning the library into pKNT25 allows the random fragment to be 
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recognised by the active site.  It was calculated that 43, 000 clones were required to cover the 
genome of C. trachomatis L2 once, assuming an average fragment size of 150 bp. This 
average fragment size was determined by restriction enzyme digest screening of 60 clones 
randomly from the library prior to screening.  A total of approximately 45, 000 clones were 
generated from the random library of which 500 exhibited a positive interaction when co-
transformed with pUT18C-S247A.  A selection of the positive clones were randomly 
isolated, sequenced and analysed for secondary structure.  There were 2 vector constructs 
with no inserts identified in these 80 clones (which had been initially selected based on 
positive interaction with HtrA) indicating a false positive rate of  at least 3.75%, consistent 
with previous reports using two-hybrid systems [Sontag, Singh et al., 2007]. Furthermore, in 
a control experiment a small aliquot of the random clone library (not known to interact) was 
spiked with pKNT25-S247A into the assay (at 10% DNA concentration relative to the library 
DNA concentration). These were screened and 10 positive interaction colonies were cultured 
and sequenced, 2 of the 10 positive interaction clones were the S247A construct, supporting 
that the assay is valid. A large diversity of sequences were identified among this positive 
population and of these, 53% were predicted to be α-helices, one of the most common 
secondary structures in proteins. Attempts to develop a consensus or heat map profile of these 
sequenced interacting clones to construct a more descriptive analysis of the in vivo binding 
determinants of CtHtrA were not successful due to the considerable diversity in length and 
amino acid sequence of the clones.  This suggests that like E. coli, CtHtrA binds a broad 
range of sequences [Jones, Dexter et al., 2002].  
 
3.4.   Residue V266 is important for CtHtrA in vivo substrate binding  
A selection of the clones which interacted with S247A were then examined by β-
galactosidase assays to quantify the level of interaction mediated by their co-transformation 
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with S247A and S247A-V266G.  Positive clones were tested in conjunction with either 
pUT18C-S247A or pUT18C-S247A with an additional site-directed mutation at V266G 
(pUT18C-S247A-V266G).  The level of β-galactosidase activity varied among the clones 
however all of the positive clones exhibited a level of interaction higher than that of the 
negative control (pUT18C co-transformed with pKNT25). No sequence type or consensus 
could be reliably generated using bioinformatic tools, even using only the top 10% of 
interacting fragments, indicating that CtHtrA is capable of binding a broad range of protein 
sequences, and potentially the impact of these protein sequences in the context of the Cya 
fusion may in fact be the determinant of binding to CtHtrA.  Interestingly however, when the 
69 of the positive clones were co-transformed with pUT18C-S247A-V266G, the 
complementation was significantly reduced (greater than 1.2 fold, p value <0.05) for 32 of 
the clones, one clone with a fold change of 1.17 was significantly different (p valuce <0.05), 
two clones exhibited a statistically significant increase in binding in the V266G mutation (FC 
<0.8, p value <0.05) (Table 2). A number of the clones which had been randomly selected for 
sequence were included in this analysis; however there was still no clear consensus of a 
binding motif based on different -gal activity observed in the presence of the V266G 
mutation. These data support that V266 is an important residue for substrate binding in 
CtHtrA, and this is in a substrate sequence dependent manner. However, it is not possible to 
tease out what aspects of the clones sequences are affected by the V266G mutation given the 
size and variability of the sequences of the clones which showed significantly different 
interactions.   This residue could be involved in substrate binding specificity given that the 
residue in this position differs in other bacterial HtrAs (as indicated by the previous 
alignment results).  Alternatively, and more likely, it could be involved in the structural 
integrity of the active site and could possibly be involved in the stabilisation of loop L2.  
Loop L2 blocks the entrance to the active site therefore when HtrA is activated it alters its 
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conformation to allow activation and access to the active site centre [Krojer, Pangerl et al., 
2008].  The residues located at the base of L2 in E. coli (L229 and I238) are believed to 
interact with each other to stabilise the L2 loop which blocks the active site, as substitution of 
either of these residues with asparagine resulted in EcHtrA losing proteolytic activity [Krojer, 
Sawa et al., 2010].  In addition these residues have also been shown to contact the LA 
regulatory loop indicating that they may be involved in the transduction of the allosteric 
signal from the PDZ [Krojer, Sawa et al., 2010].  Krojer and co-workers (2010) [Krojer, 
Sawa et al., 2008] also support the existence of protease and PDZ domain collaboration of 
substrate specificity showing that the EcHtrA protease domain binds with interacting peptide 
ligands in the same manner as its PDZ1 domain.  A similar collaboration may also exist in 
CtHtrA where V266 functions in the structural activation signal initiated from the substrate 
binding in the PDZ cleft.  Reasonably, substrate specificity of such a complex protein is 
unlikely to be controlled purely by a single residue.  Nevertheless, this study has shown that, 
V266 seems likely to be a key substrate binding determinant for CtHtrA potentially by either 
direct formation of a substrate pocket or by a structural role such as stabilisation of loop L2. 
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Experimental Procedures 
 
Molecular modelling, protein BLAST and secondary structure analysis 
The molecular models of CtHtrA structure used were acquired from a previous study 
by Huston and co-workers (2011) [Huston, Tyndall et al., 2011]. A Protein BLAST was 
conducted on loops 1 and 2 (residue 240-276) of CtHtrA using blastp located at 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins. BLAST results were aligned using 
ClustalW2 located at http://www.ebi.ac.uk/Tools/msa/clustalw2/. Secondary structures were 
predicted using the GARNIER software [Garnier, Gibrat et al., 1996] from nucleotide 
sequences translated by ExPaSy Translate tool (http://web.expasy.org/translate/). 
Protease activity and specificity assays 
CtHtrA was heterologously expressed and purified as previously described [Huston, 
Swedberg et al., 2007]. CtHtrA activity was confirmed using β-casein as a substrate [Huston, 
Swedberg et al., 2007]and confirmed to be purified to homogeneity by checking the 
preparations on coomassie stained SDS PAGE. Protease assays using recombinant wild type 
and mutant CtHtrA were performed as previously outlined in [Huston, Tyndall et al., 2011]. 
Bacterial Two Hybrid system and random library generation 
The cthtra gene was cloned in frame with the pUT18C (ampicillin) and pKNT25 
(kanamycin) vectors provided with the Bacterial Adenylate Cyclase Two Hybrid (BACTH) 
kit (Euromedex) by PCR amplification using the primers BACTH-CtHtrA-F 5’-3’: 
CGGGTACCGATGCTAGGCTATAGTGCGTCAAAG, BACTH-CtHtrA-R 5’-3’: 
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CGGGTACCGCCTCGTCTGATTTCAAGACG and cloned with restriction enzyme sites 
(underlined: KpnI).  The mip gene and segments of the gspd and yscc genes were cloned in 
frame into the pKT25 and pKNT25 vectors using the primers outlined in the supplementary 
data (Supplementary Data Table 1).  Positive interactions were observed when 
complementary plasmids (i.e. one plasmid containing cya fragment T18 and one containing 
fragment T25) were co-transformed into a cya deficient E. coli strain, DHP-1, and a blue 
colony obtained on supplemented Luria Bertani media (final concentration of 40 µg/ml X-
gal, 0.5 mM IPTG and 100 µg/ml ampicillin or 50 µg/ml kanamycin) as per manufacturer’s 
protocol outlined in the BACTH kit (Euromedex, France).  A random clone library was 
generated by digesting purified C. trachomatis L2 with Sau3A and cloning into the BamHI 
site of pKNT25.  The number (N) of colonies required to obtain a random plasmid library 
representing 90-99% of one times coverage of the entire C. trachomatis L2 genome was 
determined using the calculation described by Clarke and Carbon (1976), P=1-(1-f)N , where 
f is 0.000082857 (based on 150 bp divided by 1.4 Mb of the genome) and P is 99% 
(confirmed by sequencing) [Clarke and Carbon, 1976]. 
Site-directed mutagenesis 
Site directed mutagenesis was used to alter the active site residues S247 (tca) to 
alanine (gca), using primers published by Huston et al. (2007) [Huston, Swedberg et al., 
2007]; V266 (gtc) to glycine (ggt); I265 (att) to glycine (ggt) and I242 (att) to glycine (ggt) 
using primers previously used in Huston et al. (2011) [Huston, Tyndall et al., 2011]. 
β-galactosidase assays 
Quantification of the functional complementation of the interacting proteins was measured 
using β-galactosidase assays of permeabilised cells from overnight culture using o-
nitrophenol-β-galactosidase (ONPG) as a substrate as per the method provided by the 
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manufacturers (Euromedex, France).  Empty vectors were used as a negative control and the 
positive controls included one provided by the BACTH kit (pUT18C-zip and pKT25-zip; 
Euromedex) as well as the CtHtrA-S247A positive control (pUT18C-CtHtrA-S247A and 
pKNT25-CtHtrA-S247A; this study). Statistical difference between pUT18C-S247A and 
pUT18C-S247A-V266G β-galactosidase units per microgram protein were assessed using an 
equal variance t-test corrected for multiple testing[Benjamini and Hochberg, 1995] in the R 
statistical environment (version 2.13.1). 
15 
 
 
Acknowledgements 
The authors would like to acknowledge the funding support from the NHMRC Project Grant 
(553020, Awarded to Huston and Timms), NHMRC Peter Doherty Fellowship (Awarded to 
Huston), and QUT IHBI ECR Grant.  
 
References 
Baud, C., I. Gutsche, E. Willery, D. de Paepe, H. Derobecq, M. Gilleron, C. Locht, M. Jamin 
and F. Jacob-Dubuisson Membrane-associated DegP in Bordetella chaperones a repeat-rich 
secretory protein.(2011). Mol Microbiol; 80: 1625-35. 
Belland, R. J., D. E. Nelson, D. Virok, D. D. Crane, D. Hogan, D. Sturdevant, W. L. Beatty 
and H. D. Caldwell Transcriptome analysis of chlamydial growth during IFN-gamma-
mediated persistence and reactivation.(2003). PNAS; 100(26): 15971-15976. 
Benjamini, Y. and Y. Hochberg Controlling the false discovery rate: a practical and powerful 
approach to multiple testing.(1995). J Roy Statist Soc Ser; 57: 289-300. 
Chitlaru, T., G. Zaide, S. D. Ehrlich, I. Inbar, O. Cohen and A. Shafferman HtrA is a major 
virulence determinant of Bacillus anthracis.(2011). Mol Microbiol; 81(1542-1559). 
Clarke, L. and J. Carbon A colony bank containing synthetic ColE1 hybrid plasmids 
representative of the entire E. coli chromosome.(1976). Cell; 9: 91-99. 
Garnier, J., J. F. Gibrat and B. Robson GOR secondary structure prediction method version 
IV.(1996). Meth Enzymol; 266: 540-553. 
Ghinsberg, R. C. and Y. Nitzan Chlamydia trachomatis direct isolation, antibody prevalence 
and clinical symptoms in women attending outpatient clinics.(1994). New Microbiol; 17(3): 
231-242. 
16 
 
Hoy, B., M. Lower, C. Weydig, G. Carra, N. Tegtmeyer, T. Geppert, P. Schroder, N. Sewald, 
S. Backert, G. Schneider and S. Wessler Helicobacter pylori HtrA is a new secreted virulence 
factor that cleaves E-cadherin to disrupt intercellular adhesion.(2010). EMBO Rep; 11(10): 
798-804. 
Huston, W. M., J. E. Swedberg, J. M. Harris, T. P. Walsh, S. A. Mathews and P. Timms The 
temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a 
chaperone and protease at 37oC.(2007). FEBS Letters; 581: 3382-3386. 
Huston, W. M., J. D. Tyndall, W. B. Lott, S. H. Stansfield and P. Timms Unique Residues 
Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia 
trachomatis.(2011). PLoS One; 6(9): e24547. 
Jones, C. H., P. Dexter, A. K. Evans, C. Liu, S. J. Hultgren and D. E. Hruby Escherichia coli 
DegP protease cleaves between paired hydrophobic residues in a natural substrate: the PapA 
pilin.(2002). Journal of Bacteriology; 184(20): 5762-5771. 
Krojer, T., M. Garrido-Franco, R. Huber, M. Ehrmann and T. Clausen Crystal structure of 
DegP (HtrA) reveals a new protease-chaperone machine.(2002). Nature; 416(6879): 455-459. 
Krojer, T., K. Pangerl, J. Kurt, J. Sawa, C. Stingl, K. Mechtler, R. Huber, M. Ehrmann and T. 
Clausen Interplay of PDZ and protease domain of DegP ensures efficient elimination of 
misfolded proteins.(2008). PNAS; 105(22): 7702. 
Krojer, T., J. Sawa, R. Huber and T. Clausen HtrA proteases have a conserved activation 
mechanism that can be triggered by distinct molecular cues.(2010). Nature Struct Mol Biol; 
17(7): 844-852. 
Krojer, T., J. Sawa, E. Schäfer, H. R. Saibil, M. Ehrmann and T. Clausen Structural basis for 
the regulated protease and chaperone function of DegP.(2008). Nature; 453: 885-890. 
17 
 
Poquet, I., V. Saint, E. Seznec, N. Simoes, A. Bolotin and A. Gruss HtrA is the unique 
surface housekeeping protease in Lactococcus lactis and is required for natural protein 
processing.(2000). Molecular Microbiology; 35(5): 1042-1051. 
Sobiecka-Szkatula, A., A. Gieldon, A. Scire, F. Tanfani, D. Figaj, T. Koper, J. Ciarkowski, B. 
Lipinska and J. Skorko-Glonek The role of the L2 loop in the regulation and maintaining the 
proteolytic activity of HtrA (DegP) protein from Escherichia coli.(2010). Archives of 
Biochemistry and Biophysics; 500: 123-130. 
Sontag, D., R. Singh and B. Berger Probabilistic modeling of systematic errors in two-hybrid 
experiments.(2007). Pac Symp Biocomput. ; 1: 445-457. 
WHO (2011). "World Health Organisation 
http://www.who.int/vaccine_research/diseases/soa_std/ed/index1/html." 
Witkin, S. S. and I. M. Linhares Chlamydia trachomatis in subfertile women undergoing 
uterine instrumentation - An alternative to direct microbial testing or prophylactic antibiotic 
treatment.(2002). Human Reproduction; 17(8): 1938-1941. 
 
 
18 
 
 
 
Figure legends 
Figure 1 
Molecular model of the structure of CtHtrA protease domain. (a) Structural model of CtHtrA 
protease domain showing catalytic triad (S247, H143, D173; yellow) and flexible loop 1 
(I242; S247) and loop 2 (I265; V266) encompassing the substrate binding sites S1-S3. The 
residues predicted to be important for specificity I242, V266 and I265 shown in brown. (b) 
Schematic showing relative orientation of specificity determining residues with respect to a 
substrate (P1-P3). (c) Alignment of CtHtrA and EcHtrA loops 1 and 2; asterisks represent 
mutated residues I242, S247, I265 and V266 respectively. 
 
 
  
 
 
 
 
